Adage Capital Partners’s Cellectis CLLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-300,000
Closed -$5.34M 766
2020
Q2
$5.34M Sell
300,000
-250,000
-45% -$3.8M 0.01% 613
2020
Q1
$5.06M Sell
550,000
-25,000
-4% -$373K 0.02% 568
2019
Q4
$9.84M Hold
575,000
0.02% 539
2019
Q3
$5.98M Hold
575,000
0.01% 605
2019
Q2
$8.97M Sell
575,000
-25,000
-4% -$446K 0.02% 545
2019
Q1
$11M Hold
600,000
0.03% 505
2018
Q4
$9.99M Sell
600,000
-200,000
-25% -$4.64M 0.03% 511
2018
Q3
$22.6M Sell
800,000
-50,746
-6% -$1.46M 0.05% 372
2018
Q2
$24.1M Buy
+850,746
New +$25.3M 0.06% 365

Other funds holding CLLS

Adage Capital Partners's CLLS Position: Q3 2020 in Review

Adage Capital Partners sold out of Cellectis (CLLS) in Q3 2020, closing a stake of 300,000 shares — an estimated $5.34M sold.

Adage Capital Partners first reported a position in CLLS in Q2 2018 and held it in 9 quarters. The position peaked at $24.1M in Q2 2018. 74 funds tracked by Wall St. Rank hold CLLS as of Q3 2020.

  • Adage Capital Partners reported no remaining Cellectis position as of Q3 2020 after selling out during the quarter.
  • Adage Capital Partners sold 300,000 Cellectis shares in Q3 2020, an estimated $5.34M.
  • Adage Capital Partners first reported a position in Cellectis in Q2 2018 and held it in 9 quarters.
  • Adage Capital Partners's Cellectis position peaked at $24.1M in Q2 2018.
  • 74 funds tracked by Wall St. Rank held Cellectis as of Q3 2020.

Based on Adage Capital Partners's 13F filing for Q3 2020, filed 16 Nov 2020.